Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
LYEL | Lyell Immunopharma, Inc. | Chief General Counsel | Mar 16, 2022 | |||
TERN | Terns Pharmaceuticals, Inc. | Director | Nov 18, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|